Karen M. Bussard, Ph.D. - Publications

2008 Pennsylvania State University, State College, PA, United States 

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Booth CH, Mutkus L, Bussard K, Spaeth E, Andreeff M, Marini FC. Mesenchymal stem/stromal cell-targeted therapies for solid tumors and hematological malignancies Targeted Therapy of Acute Myeloid Leukemi. 799-819. DOI: 10.1007/978-1-4939-1393-0_43  0.92
2014 Mastro AM, Sosnoski DM, Krishnan V, Bussard KM. The influence of metastatic breast cancer on the bone microenvironment Signaling Pathways and Molecular Mediators in Metastasis. 347-368. DOI: 10.1007/978-94-007-2558-4_15  0.92
2012 Bussard KM, Smith GH. Human breast cancer cells are redirected to mammary epithelial cells upon interaction with the regenerating mammary gland microenvironment in-vivo. Plos One. 7: e49221. PMID 23155468 DOI: 10.1371/journal.pone.0049221  0.92
2011 Bussard KM, Smith GH. The mammary gland microenvironment directs progenitor cell fate in vivo. International Journal of Cell Biology. 2011: 451676. PMID 21647291 DOI: 10.1155/2011/451676  0.92
2010 Bussard KM, Boulanger CA, Kittrell FS, Behbod F, Medina D, Smith GH. Immortalized, pre-malignant epithelial cell populations contain long-lived, label-retaining cells that asymmetrically divide and retain their template DNA. Breast Cancer Research : Bcr. 12: R86. PMID 20964820 DOI: 10.1186/bcr2754  0.92
2010 Bussard KM, Venzon DJ, Mastro AM. Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer. Journal of Cellular Biochemistry. 111: 1138-48. PMID 20683902 DOI: 10.1002/jcb.22799  0.92
2010 Bussard KM, Boulanger CA, Booth BW, Bruno RD, Smith GH. Reprogramming human cancer cells in the mouse mammary gland. Cancer Research. 70: 6336-43. PMID 20647316 DOI: 10.1158/0008-5472.CAN-10-0591  0.92
2010 Bussard KM, Okita N, Sharkey N, Neuberger T, Webb A, Mastro AM. Localization of osteoblast inflammatory cytokines MCP-1 and VEGF to the matrix of the trabecula of the femur, a target area for metastatic breast cancer cell colonization. Clinical & Experimental Metastasis. 27: 331-40. PMID 20446021 DOI: 10.1007/s10585-010-9330-3  0.92
2009 Bussard KM, Mastro AM. Ex-vivo analysis of the bone microenvironment in bone metastatic breast cancer. Journal of Mammary Gland Biology and Neoplasia. 14: 387-95. PMID 19949843 DOI: 10.1007/s10911-009-9159-z  0.92
2008 Bussard KM, Gay CV, Mastro AM. The bone microenvironment in metastasis; what is special about bone? Cancer Metastasis Reviews. 27: 41-55. PMID 18071636 DOI: 10.1007/s10555-007-9109-4  0.92
2008 Kinder M, Chislock E, Bussard KM, Shuman L, Mastro AM. Metastatic breast cancer induces an osteoblast inflammatory response. Experimental Cell Research. 314: 173-83. PMID 17976581 DOI: 10.1016/j.yexcr.2007.09.021  0.92
2006 Phadke PA, Mercer RR, Harms JF, Jia Y, Frost AR, Jewell JL, Bussard KM, Nelson S, Moore C, Kappes JC, Gay CV, Mastro AM, Welch DR. Kinetics of metastatic breast cancer cell trafficking in bone. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 1431-40. PMID 16533765 DOI: 10.1158/1078-0432.CCR-05-1806  0.92
2006 Guo Z, Bussard KM, Chatterjee K, Miller R, Vogler EA, Siedlecki CA. Mathematical modeling of material-induced blood plasma coagulation. Biomaterials. 27: 796-806. PMID 16099033 DOI: 10.1016/j.biomaterials.2005.06.021  0.92
2005 Zhuo R, Miller R, Bussard KM, Siedlecki CA, Vogler EA. Procoagulant stimulus processing by the intrinsic pathway of blood plasma coagulation. Biomaterials. 26: 2965-73. PMID 15603791 DOI: 10.1016/j.biomaterials.2004.08.008  0.92
2002 Bussard KM, Vogler EA, Siedlecki CA. Effective production of FXIIa and thrombin by model biomaterials Proceedings of the Ieee Annual Northeast Bioengineering Conference, Nebec. 2002: 129-130. DOI: 10.1109/NEBC.2002.999499  0.92
Show low-probability matches.